Table 1.
List of primers used in this study
| Name | Sequence (5′ to 3′) | Reference |
|---|---|---|
| HBV NRE 1399F | TGG TAC CTG CGC GGG ACG TCC TT | This study |
| HBV NRE 1632R | AGC TAG CGT TCA CGG TGG TCT CC | This study |
| E-cad promoter S | TGC AGG TAC CAT AAC CCA CC | This study |
| E-cad promoter AS | TAC CGC TAG CTG GCT GAG GG | This study |
| HBV 379F | GTG TCT GCG GCG TTT TAT CA | 28 |
| HBV 476R | GAC AAA CGG GCA ACA TAC CTT | 28 |
| HBV M 1381F | TGT TAG GTT GTG TTG TTA ATT G | This study |
| HBV M 1724R | CAA ACA ATC TTT AAA ATA TAC CTC | This study |
| pGL3 Luc +81R | TAA CAT CTT CCA TAA TAA CT | This study |
| HBV 1442MF | GTT GAA TTT TGC GGA C | This study |
| HBV 1630MR | ATA TTC AAT AAA CGT TCA CG | This study |
| HBV 1442 UF | GTT GAA TTT TGT GGA T | This study |
| HBV 1630 UR | ATA TTC AAT AAA CAT TCA CA | This study |
| E-cadherin MF | TTA GGT TAG AGG GTT ATC GCG T | 29 |
| E-cadherin MR | TAA CTA AAA ATT CAC CTA CCG AC | 29 |
| E-cadherin UF | TTA TTT TAG GTT AGA GGG TTA TTG T | 29 |
| E-cadherin UR | CAC AAC CAA TCA ACA ACA CA | 29 |
| RAR-β MF | GGG ATG TCG AGA ACG CG | 30 |
| RAR-β MR | CGA CCA ATC CAA CCG AAA CGA | 30 |
| RAR-β UF | GGG ATG TTG AGA ATG TG | 30 |
| RAR-β UR | CAA CCA ATC CAA CCA AAA CA | 30 |